financetom
Business
financetom
/
Business
/
Karnataka Bank aims to reduce gross NPAs to 4%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Karnataka Bank aims to reduce gross NPAs to 4%
Oct 12, 2018 7:55 AM

Karnataka Bank on Friday said it aims to reduce gross NPAs (non-performing assets) to four percent.

In an interview to CNBC-TV18, Mahabaleshwara MS, managing director and chief executive officer, said the slippage is totally under control now, "If you look at the gross NPA, which was at 4.72 percent as of June 2018 and 4.92 percent as of March 2018 is now at 4.66 percent."

"The stress in the pipeline especially my SMA2 (special mention accounts) and MSME dispensation there is considerable reduction. In fact, SMA2, which was at Rs 734 crore during June 2018 is now at Rs 347 crore. Similarly, MSME dispensation, which was at Rs 319 crore about a quarter back is now at Rs 210 crore. So, this is an indication that how much is the level of stress in the pipeline," Mahabaleshwara said.

On IL&FS, he said, "We have exposure to three entities of IL&FS and all put together, our credit exposure is Rs 156 crore, which is around 0.31 percent of our total advances. All the three are standard accounts, only one account with an exposure of Rs 30.79 crore, we have treated it as SMA2."

Mahabaleshwara further added, "Net interest income (NII) moved up by 6.24 percent. The reason being that our yield on advances went up by about 11 basis points and the cost of deposit also went up by about 11 basis points. So, whatever that impact is there, for the entire deposit, it's now absorbed. So, that is the reason we are getting about 6.24 percent increase in the net interest income."

"However, there has been a re-pricing of majority of the advances ranging from about 10 basis point to 70 basis points in the last week of this quarter, which is going to get us a significant improvement in the NII and eventually in NIMs also. We should be able to maintain the NIM at about 3 percent, presently it's at 2.91 percent. So by March 2019, we should be able to get a NIM of around 3 percent," he said.

First Published:Oct 12, 2018 4:55 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novo Nordisk gets UK approval for using weight-loss drug to reduce heart risks
Novo Nordisk gets UK approval for using weight-loss drug to reduce heart risks
Jul 23, 2024
July 23 (Reuters) - Novo Nordisk's weight-loss drug Wegovy has secured the UK regulator's approval for its use to reduce the risk of overweight and obese adults suffering serious heart problems or strokes, the agency said on Tuesday. (Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur) ...
Ainos Enrolls First Subject in Taiwanese Trial for VELDONA-Based Feline FCGS Treatment
Ainos Enrolls First Subject in Taiwanese Trial for VELDONA-Based Feline FCGS Treatment
Jul 23, 2024
10:31 AM EDT, 07/23/2024 (MT Newswires) -- Ainos (AIMD) said Tuesday it enrolled the first subject in its Taiwanese clinical trial of a VELDONA-based animal drug for treating feline chronic gingivostomatitis. The first subject is scheduled to receive the dose on Friday, the company said. FCGS is a severe and painful chronic oral disease in cats, marked by inflammation or...
Nano Nuclear Files Provisional Patent Applications For Annular Linear Induction Pump Technology
Nano Nuclear Files Provisional Patent Applications For Annular Linear Induction Pump Technology
Jul 23, 2024
10:30 AM EDT, 07/23/2024 (MT Newswires) -- Nano Nuclear Energy ( NNE ) said Tuesday it has filed a series of provisional patent applications with the US Patent and Trademark Office to secure intellectual property protection for its recently acquired annular linear induction pump technology. The pump is a key enabling technology for its ODIN microreactor in development and the...
Tivic Health Systems Gets 3 New Patents in US, Europe
Tivic Health Systems Gets 3 New Patents in US, Europe
Jul 23, 2024
10:31 AM EDT, 07/23/2024 (MT Newswires) -- Tivic Health Systems ( TIVC ) said Tuesday it has received three new patents in the US and Europe. The company said it has received the patents Sinus Treatment Device With Adaptive Circuit from the European Patent Office and Adaptive Trigger for a Microcurrent Stimulation Device from Europe and the US Patent and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved